---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-107402"
form_type: "8-K"
ticker: "JSPR"
cik: "0001788028"
company_name: "Jasper Therapeutics, Inc."
filed_at: "2026-10-07T12:05:39+00:00"
generated_at: "2026-10-12T16:00:21.501123+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Jasper Therapeutics offers $0.324 cash per warrant to retire 12,345,707 outstanding warrants, ~$4.0M max outlay

## Summary
- Tender offer at $0.324 in cash per warrant, without interest; warrants were issued in Jasper's September 18, 2025 underwritten public offering.
- 12,345,707 warrants were outstanding as of October 6, 2026; if all are tendered the company expects to pay about $4.0 million from cash on hand.
- Each warrant entitles the holder to buy one share of common stock at $2.92; tendered warrants are retired and cancelled rather than resold.
- Offer expires one minute after 11:59 p.m. ET on November 6, 2026, unless extended; tenders may be withdrawn any time before the deadline.
- Untendered warrants stay outstanding on original terms and expire at 5:00 p.m. ET on March 18, 2030; the offer has no minimum tender condition.

## SEC filing metadata
- accession: 0001213900-26-107402
- form_type: 8-K
- ticker: JSPR
- cik: 0001788028
- company_name: Jasper Therapeutics, Inc.
- filed_at: 2026-10-07T12:05:39+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1788028/000121390026107402/0001213900-26-107402-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1788028/000121390026107402/ea0307925-8k_jasper.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-107402
- JSON: https://secwatch.observer/filing/0001213900-26-107402.json
- Plain text: https://secwatch.observer/filing/0001213900-26-107402.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.